Blood Cancer Drugs Market

19 May

Sample

Blood Cancer Drugs Market Poised to Grow at a CAGR between 10.5% to 11.5% by 2023

  • By admin

  • January, 1970

Infinium Global Research has added a new report on Blood Cancer Drugs Market. The report presents analysis of global as well as regional markets of blood cancer drugs market over the period of 2015 to 2023. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global blood cancer drugs market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2017-2023.

 

Get 15% discount for early purchase of global blood cancer drugs market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/20

 

The recent report identified that North America dominated the global blood cancer drugs market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the blood cancer drugs market worldwide.

 

The report segments the global blood cancer drugs market on the basis of product.

 

Global Blood Cancer Drugs Market by Product

·         Rituaxan/Mabthera (Rituximab)

·         Gleevac/Glivec (Imatinib)

·         Revlimid (Lenalidomide)

·         Velcade (Bortezomib)

·         Tasigna (Nilotinib)

·         Pomalyst (Pomalidomide)

·         Vidaza (Azacitidine)

·         Kyprolis (Carfilzomib)

·         Adcetris (Brentuximab Vedotin)

·         Others

 

Companies Profiled in the Report

·         Amgen Inc

·         AstraZeneca PLC

·         Astellas Pharma Inc

·         Bayer AG

·         Bristol-Myers Squibb Company

·         Celgene Corporation

·         Eli Lilly

·         F.Hoffmann-La Roche Ltd

·         Johnson & Johnson

·         Novartis

·         Pfizer Inc

·         Takeda Pharmaceutical Company Ltd

·         AbbVie Inc

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.